<DOC>
	<DOCNO>NCT00802828</DOCNO>
	<brief_summary>Compare rate extent absorption famotidine 40 mg tablet , administer 1 x 40 mg tablet fast condition .</brief_summary>
	<brief_title>Bioequivalence Study Between Two Oral Formulations Famotidine Tablets Under Fasting Conditions</brief_title>
	<detailed_description />
	<mesh_term>Famotidine</mesh_term>
	<criteria>healthy men woman 18 year age old body mass index 30.0 kg/m2 willing participate sin copy inform consent form recent history drug alcohol addiction abuse pregnant lactating woman history allergic response heparin , famotidine , H2receptor antagonists , related drug evidence clinically significant disorder whose laboratory result deem clinically significant recipient drug part research study within 30 day prior study dose</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>bioavailability</keyword>
	<keyword>famotidine</keyword>
</DOC>